GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (FRA:0EH) » Definitions » EV-to-Revenue

Toleranzia AB (FRA:0EH) EV-to-Revenue : (As of May. 26, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Toleranzia AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Toleranzia AB's enterprise value is €8.92 Mil. Toleranzia AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil. Therefore, Toleranzia AB's EV-to-Revenue for today is .

The historical rank and industry rank for Toleranzia AB's EV-to-Revenue or its related term are showing as below:

During the past 10 years, the highest EV-to-Revenue of Toleranzia AB was 1239.20. The lowest was -266.69. And the median was 42.93.

FRA:0EH's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.285
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Toleranzia AB's stock price is €0.0312. Toleranzia AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00. Therefore, Toleranzia AB's PS Ratio for today is .


Toleranzia AB EV-to-Revenue Historical Data

The historical data trend for Toleranzia AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB EV-to-Revenue Chart

Toleranzia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Toleranzia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Toleranzia AB's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Toleranzia AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Toleranzia AB's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Toleranzia AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Toleranzia AB's EV-to-Revenue falls into.



Toleranzia AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Toleranzia AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8.915/0
=

Toleranzia AB's current Enterprise Value is €8.92 Mil.
Toleranzia AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Toleranzia AB  (FRA:0EH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Toleranzia AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.0312/0
=

Toleranzia AB's share price for today is €0.0312.
Toleranzia AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Toleranzia AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Toleranzia AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Toleranzia AB (FRA:0EH) Business Description

Traded in Other Exchanges
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.

Toleranzia AB (FRA:0EH) Headlines

No Headlines